MOREPENLAB2026-05-262026-05-26MOREPENLAB2026-05-26xbrli:pureMOREPENLABMOREPEN LABORATORIES LIMITEDUpdateOthersSecond addendum to the Business Transfer Agreement dated 18th March 2025 (as amened on 12th May 2025)Revision, Rescission, Amendment or Alteration of agreementListed Entity,Related Parties of the listed entitytrue2026-05-2617:15:00true2025-03-182026-05-262026-05-262025-03-18Owing to the time involved in obtaining the requisite statutory licenses, regulatory approvals, and completion of procedural formalities, the second addendum to the aforesaid BTA is being executed today, i.e., 26th May 2026, to further revise the “Appointed Date” to 1st April 2026.2Morepen Laboratories Limited (‘the Company’) and Morepen Medipath Limited (‘MML’), formerly known as Morepen Medtech Limited, a subsidiary of the CompanySecond Addendum to Business Transfer Agreement2026-05-26The second addendum to the BTA records the further revision of the 'appointed date' on which ownership of the undertaking is being transferred by the Company to MML. The effect of this change (including valuation) would be applied appropriately to the relevant provisions of the BTA, while the remainder of the agreement remains unchanged and fully effective. Apart from the aforesaid, there will be no impact on the entire transaction. The Company had executed first Addendum to Business Transfer Agreement on May 12, 2025.